Quest Diagnostics
DGX
#950
Rank
โ‚น2.467 T
Marketcap
โ‚น22,353
Share price
0.07%
Change (1 day)
38.84%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

EPS for Quest Diagnostics (DGX)

EPS in 2026 (TTM): โ‚น877.64

According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is โ‚น923.28. In 2025 the company made an earnings per share (EPS) of โ‚น858.44 an increase over its 2024 EPS that were of โ‚น752.95.

EPS history for Quest Diagnostics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น877.642.24%
2025โ‚น858.4414.01%
2024โ‚น752.952.5%
2023โ‚น734.56-5.83%
2022โ‚น780.05-49.21%
2021โ‚น1,53649.72%
2020โ‚น1,02666.67%
2019โ‚น615.5218%
2018โ‚น521.64-4.26%
2017โ‚น544.8723.19%
2016โ‚น442.28-7.11%
2015โ‚น476.1628.46%
2014โ‚น370.67-31.61%
2013โ‚น541.9760.46%
2012โ‚น337.76

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
LabCorp
LH
โ‚น1,178 27.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-โ‚น68.89-107.46%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น38.71-104.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น192.09-79.19%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-โ‚น20.32-102.20%๐Ÿ‡บ๐Ÿ‡ธ USA